Aterosklerotska kardiovaskularna bolest – imamo li način da je usporimo?/Atherosclerotic cardiovascular disease- Do we have a way of slowing it down
Efikasnost u glikemijskoj kontroli GLP-1RA / Efficacy of glycemic control of GLP-1RA
Aleksandra Jotić (Belgrade, RS)
Metabolički efekti GLP-1RA / Metabolic effects of GLP-1RA
Katarina Lalić (Belgrade, RS)
Uticaj GLP-1RA na aterosklerotski plak / Impact of GLP-1RA on atherosclerotic plaques
Arsen Ristić (Belgrade, RS)
Sponsored by Novo Nordisk